It has been reported that neurotensin (NT) and neurotensin receptors (NTRs) could play key roles in prostate cancer progression, especially when deprived of androgens [16], and in the development of castration-resistant PCa with neuroendocrine differentiation (NED) [17]. The gene discussed is NTS; the disease is prostate carcinoma.